Your gastrointestinal tract uses a combination of stomach stretching, peptide hormones like GLP-1, ghrelin, motilin, and CCK, and neural pathways to tell your brain when to eat and when to stop.
Motilin = hunger triggerMotilin release driving gastric Phase 3 (the stomach's cleaning waves) was identified as the major determinant of hunger returning after a meal
What the researchers found
Gastric accommodation is the major determinant of meal volume, motilin drives return of hunger, and GLP-1/CCK/ghrelin/PYY provide hormonal gut-brain signaling for hunger and satiety regulation.
Why it matters
Understanding the gut signals that control eating is fundamental to treating obesity and eating disorders. These are the same pathways targeted by GLP-1 drugs and other appetite medications.
The numbers in context
Gastric accommodation: major meal volume determinant; motilin: hunger return via phase 3; GLP-1, CCK, PYY: satiety; ghrelin: hunger; bitter tastants and GLP-1 analogs modulate pathways
How the study worked
Narrative review of gastrointestinal mechanisms involved in hunger and satiety signaling, covering mechano/chemoreceptors, peptide hormones, and neural pathways.
Who was studied
Narrative review of gastrointestinal hunger and satiety signaling mechanisms
What this study cannot tell us
Narrative review. Some mechanisms are better studied than others. Motilin's role in hunger is well-supported but less studied therapeutically. Individual variation in these pathways is not addressed.
How to read the evidence
This is a narrative review synthesizing established knowledge about gut-brain appetite signaling. It provides an excellent educational overview but does not present new data or use systematic review methodology.
When this study was published
Published in 2021, this review covers the state of knowledge before the widespread adoption of tirzepatide and other newer dual-agonist drugs, but the core physiology it describes remains current and accurate.
The bigger picture
This review provides the biological foundation for understanding why GLP-1 drugs, ghrelin modulators, and other peptide-based appetite therapies work. The gut-brain axis described here is the target of the most successful weight loss medications in history. Understanding these peptide signaling pathways also illuminates conditions like functional dyspepsia, irritable bowel syndrome, and eating disorders where these signals go awry.
Questions still open
- Could targeting motilin pharmacologically provide a new approach to appetite control distinct from GLP-1 drugs?
- How do these gut peptide signals change after bariatric surgery, and does that explain the surgery's weight loss effects?
- Why do some individuals seem resistant to normal satiety signaling despite intact peptide hormone release?
Common questions
Why does your stomach need to relax when you eat?
What makes you feel hungry again after a meal?
Read the original research
The gastrointestinal tract in hunger and satiety signalling.
United European gastroenterology journal, 9(6), 727-734
Citation
Tack, Jan; Verbeure, Wout; Mori, Hideki; Schol, Jolien; Van den Houte, Karen; Huang, I-Hsuan; Balsiger, Lukas; Broeders, Bert; Colomier, Esther; Scarpellini, Emidio; Carbone, Florencia. (2021). The gastrointestinal tract in hunger and satiety signalling.. United European gastroenterology journal, 9(6), 727-734. https://doi.org/10.1002/ueg2.12097